Cargando…

FIDEPOC: Consensus on Inspiratory Flow and Lung Deposition as Key Decision Factors in COPD Inhaled Therapy

PURPOSE: The pharmacological treatment of chronic obstructive pulmonary disease (COPD) is largely based on inhaled bronchodilators. Inspiratory flow and lung deposition are key parameters to be considered in inhaled therapy; however, the relationship between these two parameters, the patient specifi...

Descripción completa

Detalles Bibliográficos
Autores principales:	González-Torralba, Fernando, Baloira, Adolfo, Abad, Araceli, Fuster, Antonia, García-Rivero, Juan Luis, García-Sidro, Patricia, Márquez-Martín, Eduardo, Palop, Marta, Soler, Néstor, Velasco, José Luis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081625/ https://www.ncbi.nlm.nih.gov/pubmed/35547784 http://dx.doi.org/10.2147/COPD.S360938

Ejemplares similares

Lung Deposition and Inspiratory Flow Rate in Patients with Chronic Obstructive Pulmonary Disease Using Different Inhalation Devices: A Systematic Literature Review and Expert Opinion
por: Baloira, Adolfo, et al.
Publicado: (2021)

Relationship Between Clinical Control, Respiratory Symptoms and Quality of Life for Patients with COPD
por: Alcazar-Navarrete, Bernardino, et al.
Publicado: (2020)

Peak-Inspiratory-Flow-Rate Guided Inhalation Therapy Reduce Severe Exacerbation of COPD
por: Chen, Shih-Yu, et al.
Publicado: (2021)

Evaluation of Suboptimal Peak Inspiratory Flow in Patients with Stable COPD
por: Represas-Represas, Cristina, et al.
Publicado: (2020)

Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs
por: Leving, Marika T, et al.
Publicado: (2022)

Inspiratory flow profile and usability of the NEXThaler, a multidose dry powder inhaler, in asthma and COPD
por: Chetta, Alfredo, et al.
Publicado: (2021)

Inhaled treatment of COPD: a Delphi consensus statement
por: Ninane, Vincent, et al.
Publicado: (2017)

The Confusing World of Dry Powder Inhalers: It Is All About Inspiratory Pressures, Not Inspiratory Flow Rates
por: Clark, Andrew R., et al.
Publicado: (2020)

Do not do in COPD: consensus statement on overuse
por: Villar-Álvarez, Felipe, et al.
Publicado: (2018)

A cross-sectional study to assess inhalation device handling and patient satisfaction in COPD
por: Miravitlles, Marc, et al.
Publicado: (2016)

Benefits of short inspiratory muscle training on exercise capacity, dyspnea, and inspiratory fraction in COPD patients
por: Shahin, Barakat, et al.
Publicado: (2008)

Inspiratory muscle strength and walking capacity in patients with COPD
por: Kofod, Linette Marie, et al.
Publicado: (2019)

A Delphi Consensus Document on the Use of Single-Inhaler Fixed-Dose Triple Therapies in COPD Patients
por: López-Campos, José Luis, et al.
Publicado: (2020)

Inspiratory Flow Parameters Through Dry Powder Inhalers in Healthy Volunteers and Patients with Chronic Obstructive Pulmonary Disease (COPD): Device Resistance Does Not Limit Use in COPD
por: Jõgi, Rain, et al.
Publicado: (2021)

Consensus on the Management of the COPD Patient in the COVID-19 Setting: COPD Forum Working Group
por: Calle Rubio, Myriam, et al.
Publicado: (2022)

Clinical relevance of maximal inspiratory pressure: determination in COPD exacerbation
por: Tudorache, Voicu, et al.
Publicado: (2010)

Inspiratory drive is related to dynamic pulmonary hyperinflation in COPD patients
por: Gatta, Diego, et al.
Publicado: (2013)

Effects of inspiratory muscle training on dynamic hyperinflation in patients with COPD
por: Petrovic, Milos, et al.
Publicado: (2012)

Comparison of peak inspiratory flow rate via the Breezhaler®, Ellipta® and HandiHaler® dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial
por: Altman, Pablo, et al.
Publicado: (2018)

Assessment of inhalation flow patterns of soft mist inhaler co-prescribed with dry powder inhaler using inspiratory flow meter for multi inhalation devices
por: Hira, Daiki, et al.
Publicado: (2018)

Usefulness of inspiratory capacity measurement in COPD patients in the primary care setting
por: Madueño, Antonio, et al.
Publicado: (2009)

Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD
por: O'Donnell, Denis E., et al.
Publicado: (2017)

Prevalence and factors associated with suboptimal peak inspiratory flow rates in COPD
por: Ghosh, Sohini, et al.
Publicado: (2019)

The BODE index and inspiratory muscle performance in COPD: Clinical findings and implications
por: Formiga, Magno F, et al.
Publicado: (2018)

Are the “critical” inspiratory constraints actually decisive to limit exercise tolerance in COPD?
por: Marillier, Mathieu, et al.
Publicado: (2020)

Inspiratory crackles—early and late—revisited: identifying COPD by crackle characteristics
por: Melbye, Hasse, et al.
Publicado: (2021)

TRONARTO: A Randomized, Placebo-Controlled Study of Tiotropium/Olodaterol Delivered via Soft Mist Inhaler in COPD Patients Stratified by Peak Inspiratory Flow
por: Mahler, Donald A, et al.
Publicado: (2021)

Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow
por: Huber, Bärbel, et al.
Publicado: (2022)

The dose of inhaled corticosteroids in patients with COPD: when less is better
por: Izquierdo, José Luis, et al.
Publicado: (2018)

Seasonal variability in clinical care of COPD outpatients: results from the Andalusian COPD audit
por: López-Campos, Jose Luis, et al.
Publicado: (2017)

Course of COPD assessment test (CAT) and clinical COPD questionnaire (CCQ) scores during recovery from exacerbations of chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2013)

Evaluation of Peak Inspiratory Flow Rate in Hospitalized Palliative Care Patients with COPD
por: Borris, Joshua, et al.
Publicado: (2023)

Performance Evaluation of Fixed Sample Entropy in Myographic Signals for Inspiratory Muscle Activity Estimation
por: Lozano-García, Manuel, et al.
Publicado: (2019)

Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
por: Plaza, Vicente, et al.
Publicado: (2016)

Effects of a Rehabilitation Programme with a Nasal Inspiratory Restriction Device on Exercise Capacity and Quality of Life in COPD
por: Arnedillo, Aurelio, et al.
Publicado: (2020)

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial
por: Paly, Victoria Federico, et al.
Publicado: (2022)

Matching the Inhaler to the Patient in COPD
por: Peché, Rudi, et al.
Publicado: (2021)

The evaluation of a remote support program on quality of life and evolution of disease in COPD patients with frequent exacerbations
por: Alcazar, Bernardino, et al.
Publicado: (2016)

Inappropriate Peak Inspiratory Flow Rate with Dry Powder Inhaler in Chronic Obstructive Pulmonary Disease
por: Chen, Shih-Yu, et al.
Publicado: (2020)

A pilot study of inspiratory capacity and resting dyspnea correlations in exacerbations of COPD and asthma
por: Pretto, Jeffrey J, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p2dqr3bm51tj8955m6minsk0r2